An article published in the journal Biomaterials shows that CuS@MnO2 nanoparticles (NPs) synthesized with a short bacteriophage-selected mesenchymal stem cell (MSC) targeting peptide allowed the MSCs to take up these NPs. NP-modified MSCs produced greatly improved therapy of Rheumatoid Arthritis (RA) using stem cells.
Source: AZO Nano